Dr. Michelle Henry is a Harvard trained, board certified dermatologist. She is currently a Clinical Instructor of Dermatology at Weill Cornell Medical College. She practices Mohs micrographic, reconstructive and cosmetic surgery. Dr. Henry attended medical school at Baylor College of Medicine in Houston, Texas and completed her residency in dermatology at Mount Sinai Hospital in New York City, where she served as Chief Resident. Following residency, she completed a fellowship in cutaneous oncology, Mohs micrographic and reconstructive surgery with the Harvard Medical School Department of Dermatology at the Lahey Clinic in Boston, Massachusetts. She specializes in high risk skin cancer treatments, Aesthetic Surgery, and Skin of Color. Dr. Henry has extensive experience in teaching physicians aesthetic procedures such as injecting neuromodulators (Botox ® and Dysport®), injecting fillers (Restylane®, Juvederm®, Perlane®, Belotero® and Radiesse®), laser surgery, and hair restoration. She has published numerous articles and chapters on skin cancer treatment and cosmetic surgery, including publications in Dermatologic Surgery on complex reconstruction techniques after Mohs surgery, new surgical techniques for basal cell carcinoma, and innovative uses for photodynamic therapy. She is a committed research scientist, who was recently recognized as a Tromovitch Award finalist by the American College of Mohs Surgery. Her treatment philosophy is to provide holistic care while utilizing the latest techniques and scientific data. She is a fellow of the American Academy of Dermatology, American Society of Dermatologic Surgery, and the American College of Mohs Surgery. She chairs the Education Committee of the American Society for Dermatologic Surgery and serves on the Scientific Advisory Board for Bevel (a Walker and Company brand) and BTG International Ltd. Produced for: Bioré, Curél, John Frieda